Phenotypic Analysis of Freshly Isolated Natural Killer (NK) Leukemic Cells and the Cell Line NK-YS
| Antigen . | Fresh Leukemic Cells . | NK-YS-150 . |
|---|---|---|
| CD1a | − | − |
| CD2 | +++ | ++ |
| CD3 | − | − |
| CD4 | − | − |
| CD5 | +++ | ++ |
| CD6 | − | − |
| CD7 | +++ | ++ |
| CD8 | − | − |
| CD10 | − | − |
| CD11a | ND | +++ |
| CD11b | ND | − |
| CD11c | ND | ++ |
| CD14 | − | − |
| CD15 | − | − |
| CD16 | − | − |
| CD19 | − | − |
| CD20 | − | − |
| CD21 | − | − |
| CD25 | − | +++ |
| CD33 | − | − |
| CD34 | − | − |
| CD38 | +++ | ++ |
| CD45 | ND | +++ |
| CD56 | +++ | +++ |
| CD57 | − | − |
| CD58 | + | ++ |
| CD95 (Fas) | ND | +++ |
| TcR αβ | ND | − |
| TcR γδ | ND | − |
| Sm-Ig (κ + λ) | ND | − |
| Antigen . | Fresh Leukemic Cells . | NK-YS-150 . |
|---|---|---|
| CD1a | − | − |
| CD2 | +++ | ++ |
| CD3 | − | − |
| CD4 | − | − |
| CD5 | +++ | ++ |
| CD6 | − | − |
| CD7 | +++ | ++ |
| CD8 | − | − |
| CD10 | − | − |
| CD11a | ND | +++ |
| CD11b | ND | − |
| CD11c | ND | ++ |
| CD14 | − | − |
| CD15 | − | − |
| CD16 | − | − |
| CD19 | − | − |
| CD20 | − | − |
| CD21 | − | − |
| CD25 | − | +++ |
| CD33 | − | − |
| CD34 | − | − |
| CD38 | +++ | ++ |
| CD45 | ND | +++ |
| CD56 | +++ | +++ |
| CD57 | − | − |
| CD58 | + | ++ |
| CD95 (Fas) | ND | +++ |
| TcR αβ | ND | − |
| TcR γδ | ND | − |
| Sm-Ig (κ + λ) | ND | − |
Abbreviations: ND, not determined.
+++, >75% positive; ++, 10% to 75% positive; +, <10% positive; −, negative.